Literature DB >> 10599851

Identification and distribution of Parkin in rat brain.

J M Horowitz1, J Myers, M K Stachowiak, G Torres.   

Abstract

Mutations within the amino acid sequence of Parkin, the encoded protein of the parkin gene, appear to trigger the degeneration of dopaminergic neurons in the substantia nigra. Here, the presence and anatomical distribution of Parkin within the rat was examined. Immunoblot analysis of tissue homogenates showed two major bands at 50 and 44kDa. Within the brain, Parkin-containing neurons were identified in the basal ganglia, including the substantia nigra and caudate-putamen. Parkin was visualized in the raphe nucleus, which as in the substantia nigra, was closely localized to monoaminergic-encoding neurons. In addition, Parkin was detected in laminar structures such as the cortex and hippocampus; a substantial number of Parkin-immunoreactive neurons was seen in the cerebellum as well. Parkin therefore is widely distributed in brain pathways implicated in the pathology of Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10599851     DOI: 10.1097/00001756-199911080-00025

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  12 in total

1.  Altered hippocampal synaptic physiology in aged parkin-deficient mice.

Authors:  Jesse E Hanson; Adrienne L Orr; Daniel V Madison
Journal:  Neuromolecular Med       Date:  2010-03-16       Impact factor: 3.843

2.  STEP61 is a substrate of the E3 ligase parkin and is upregulated in Parkinson's disease.

Authors:  Pradeep K Kurup; Jian Xu; Rita Alexandra Videira; Chimezie Ononenyi; Graça Baltazar; Paul J Lombroso; Angus C Nairn
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-12       Impact factor: 11.205

3.  Proteomic Analysis of Parkin Isoforms Expression in Different Rat Brain Areas.

Authors:  Agata Grazia D'Amico; Grazia Maugeri; Rita Reitano; Sebastiano Cavallaro; Velia D'Agata
Journal:  Protein J       Date:  2016-10       Impact factor: 2.371

4.  Potential roles of neuronal nitric oxide synthase and the PTEN-induced kinase 1 (PINK1)/Parkin pathway for mitochondrial protein degradation in disuse-induced soleus muscle atrophy in adult rats.

Authors:  Munehiro Uda; Toshinori Yoshihara; Noriko Ichinoseki-Sekine; Takeshi Baba; Toshitada Yoshioka
Journal:  PLoS One       Date:  2020-12-09       Impact factor: 3.240

5.  The role of parkin in the differential susceptibility of tuberoinfundibular and nigrostriatal dopamine neurons to acute toxicant exposure.

Authors:  Matthew J Benskey; Fredric P Manfredsson; Keith J Lookingland; John L Goudreau
Journal:  Neurotoxicology       Date:  2014-11-20       Impact factor: 4.294

6.  Overexpression of parkin in the rat nigrostriatal dopamine system protects against methamphetamine neurotoxicity.

Authors:  Bin Liu; Roberta Traini; Bryan Killinger; Bernard Schneider; Anna Moszczynska
Journal:  Exp Neurol       Date:  2013-01-09       Impact factor: 5.330

Review 7.  Splicing: is there an alternative contribution to Parkinson's disease?

Authors:  Valentina La Cognata; Velia D'Agata; Francesca Cavalcanti; Sebastiano Cavallaro
Journal:  Neurogenetics       Date:  2015-05-16       Impact factor: 2.660

8.  Increasing the Coding Potential of Genomes Through Alternative Splicing: The Case of PARK2 Gene.

Authors:  Valentina La Cognata; Rosario Iemmolo; Velia D'Agata; Soraya Scuderi; Filippo Drago; Mario Zappia; Sebastiano Cavallaro
Journal:  Curr Genomics       Date:  2014-06       Impact factor: 2.236

9.  Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson's Disease.

Authors:  Anna Oczkowska; Wojciech Kozubski; Margarita Lianeri; Jolanta Dorszewska
Journal:  Curr Genomics       Date:  2013-12       Impact factor: 2.236

Review 10.  Oxidative stress mechanisms underlying Parkinson's disease-associated neurodegeneration in C. elegans.

Authors:  Sudipta Chakraborty; Julia Bornhorst; Thuy T Nguyen; Michael Aschner
Journal:  Int J Mol Sci       Date:  2013-11-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.